ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $894,000 | -89.5% | 612,100 | -89.8% | 0.00% | -100.0% |
| Q4 2016 | $8,500,000 | -64.2% | 5,985,652 | -55.9% | 0.00% | -66.7% |
| Q3 2016 | $23,767,000 | +2.9% | 13,581,301 | +0.5% | 0.00% | 0.0% |
| Q2 2016 | $23,103,000 | -20.0% | 13,510,395 | -7.9% | 0.00% | -25.0% |
| Q1 2016 | $28,892,000 | +7.7% | 14,666,095 | +3.8% | 0.00% | 0.0% |
| Q4 2015 | $26,835,000 | +15.1% | 14,123,752 | +15.7% | 0.00% | +33.3% |
| Q3 2015 | $23,315,000 | -54.2% | 12,206,700 | +11.2% | 0.00% | -57.1% |
| Q2 2015 | $50,938,000 | +18.9% | 10,978,201 | +12.0% | 0.01% | +40.0% |
| Q1 2015 | $42,826,000 | +17099.2% | 9,800,000 | +16405.8% | 0.01% | – |
| Q3 2014 | $249,000 | -28.4% | 59,373 | 0.0% | 0.00% | – |
| Q2 2014 | $348,000 | -7.0% | 59,373 | 0.0% | 0.00% | – |
| Q1 2014 | $374,000 | +7.8% | 59,373 | 0.0% | 0.00% | – |
| Q4 2013 | $347,000 | -97.7% | 59,373 | -98.0% | 0.00% | -100.0% |
| Q3 2013 | $15,291,000 | +12.2% | 2,901,573 | +63.9% | 0.00% | 0.0% |
| Q2 2013 | $13,630,000 | – | 1,770,073 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 7,500,000 | $34,800,000 | 2.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,983,710 | $32,404,000 | 1.08% |
| DAFNA Capital Management LLC | 189,000 | $877,000 | 0.74% |
| Lyons Wealth Management, LLC. | 56,665 | $264,000 | 0.30% |
| Telemetry Investments, L.L.C. | 110,000 | $510,000 | 0.23% |
| Callan Capital, LLC | 232,000 | $1,076,000 | 0.23% |
| OXFORD ASSET MANAGEMENT LLP | 968,446 | $4,494,000 | 0.12% |
| FEDERATED HERMES, INC. | 5,641,200 | $26,175,000 | 0.08% |
| HRT FINANCIAL LP | 31,973 | $148,000 | 0.07% |
| WELLINGTON MANAGEMENT GROUP LLP | 33,885,551 | $157,230,000 | 0.04% |